Insider filing · GALT
Harold H. Shlevin
Director
profile →
Galectin Therapeutics Inc.
GALT · Healthcare · 14 filings in 24 months
ticker →
Harold H. Shlevin sold $1.0M of Galectin Therapeutics (GALT)
Executed Dec 8 2025, disclosed Dec 10 2025, 2 days later.
Value, as filed
$1.0M
171,790 sh across 7 lots
Executed
Dec 8 2025
the trade date, as filed
Disclosed
Dec 10 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HSHarold H. Shlevin (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $1.0M of GALT (171,790 sh across 7 lots, as filed), executed Dec 8 2025.
The name
GALTHealthcare · Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic di…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Harold H. Shlevin in GALT
GALTSALE
Galectin Therapeutics Inc.
$112K22,268 sh × $5.04
Exec Jun 29
Filed Jun 30 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. $139K
19,793 sh × $7.04
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. $124K
19,793 sh × $6.27
Exec Dec 12 2025
Filed Dec 16 2025 · 5:30 PM ET